✦ LIBER ✦

Barnidipine, a Novel Calcium Antagonist for Once-Daily Treatment of Hypertension: A Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study

✍ Scribed by Wimpeter Hart; Nicolas J. Holwerda

Book ID: 110254561
Publisher: Springer US
Year: 1997
Tongue: English
Weight: 177 KB
Volume: 11
Category: Article
ISSN: 0920-3206
DOI: 10.1023/a:1007778706354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily fexofenadine treatment for ch

Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study

✍ Kaplan, Allen P.; Spector, Sheldon L.; Meeves, Suzanne; Liao, Yuning; Varghese, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Amlodipine: A once-daily calcium antagon

Amlodipine: A once-daily calcium antagonist in the treatment of angina pectoris—A parallel dose-response, placebo-controlled study

✍ Udho Thadani 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Once-daily eprosartan mesylate in the tr

Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study

✍ Punzi, H A; Punzi, C F 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB

Efficacy and Safety of Once-Daily Dosing

Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Chen Zhao; Sae Woong Kim; Dae Yul Yang; Je Jong Kim; Nam Cheol Park; Sung Won Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

Efficacy and Safety of Once-Daily Dosing

Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Shindel, A.W. 📂 Article 📅 2012 🏛 Elsevier Science ⚖ 51 KB

Doxazosin for the Treatment of Benign Pr

Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study

✍ Gillenwater, Jay Y.; Conn, Richard L.; Chrysant, Steven G.; Roy, Johnny; Gaffney 📂 Article 📅 1995 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 606 KB